Home / Inspections / 1009640

FDA Inspection 1009640 — Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center — FEI 1273763

The FDA completed an inspection of Beth Israel Deaconess Medical Center on April 19, 2017 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 19, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)

Facility

Other inspections at this facility

  • 1270644 (NAI Wed Apr 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1218205 (NAI Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1095042 (NAI Mon Jun 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 914552 (NAI Fri Feb 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836793 (NAI Wed Jun 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources